A Pipeline for MRI-Guided dose painting by number radiation Therapy: GLIORAD − a phase I-II clinical trial in recurrent glioblastoma

A. Botti(Azienda Sanitaria Unità Locale di Reggio Emilia), Mauro Iori(Azienda Sanitaria Unità Locale di Reggio Emilia), Lucia Giaccherini(Azienda Sanitaria Unità Locale di Reggio Emilia), Giulia Paolani(Azienda Sanitaria Unità Locale di Reggio Emilia), Matteo Orlandi(Azienda Sanitaria Unità Locale di Reggio Emilia), Cinzia Iotti(Azienda Sanitaria Unità Locale di Reggio Emilia), Roberto Sghedoni(Azienda Ospedaliera S.Maria), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia)
Physica Medica
March 27, 2026
10.1016/j.ejmp.2026.105773
Cited by 0

Related Papers

Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|Lung Cancer|2009|277
Stereotactic body radiation therapy for lung metastases
|Lung Cancer|2011|146
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
|European Urology|2021|110
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations
|Radiation Oncology|2012|109
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO
|Neuro-Oncology|2021|91